Back to Top
Enews Now
July 2017
In the News
The article “Prevalence of food allergies and intolerances documented in electronic health records,” published in The Journal of Allergy and Clinical Immunology (JACI), garnered media attention from multiple outlets including The New York Times, Forbes and Science Daily.
News Briefs
Present Your Research at the 2018 AAAAI/WAO Joint Congress
The abstract and case report submission site is now open. Submit your research or interesting patient care experiences today. Read more »
AAAAI Journals Continue to Show Progress with Latest Impact Factors
Thanks to the support of members and subscribers, the journal editorial teams are proud to present the 2016 impact factors. Read more »
FDA Approves Epinephrine Injection and Subcutaneous Hereditary Angioedema Drug
The FDA recently approved an epinephrine injection as well as the first subcutaneous, preventative therapy for hereditary angioedema. Read more »
Web Tips

Get Direct Access to Popular Pages on the AAAAI Website

Are you looking for practice parameters or other important resources on the AAAAI website? Visit the Direct Access Links page for fast access to popular website pages.

Need CME? Check Out Our Latest Educational Content

Find our catalog of online educational content at, including courses on immunotherapy, food allergy and asthma.

From the President

Dear Colleagues,

What place does allergy/immunology (A/I) have in the changing healthcare environment? This is a crucial question and one of my presidential initiatives aims to answer it.

We cannot deny that our specialty faces certain challenges. We are underrepresented in medical schools and few A/I physicians occupy national decision-making roles. Not to mention the changes in healthcare reimbursement models, the regulatory and research environment, and diagnostic techniques and treatments for allergic diseases. Consider that 60% of practice revenue associated with skin testing and traditional immunotherapy may be at risk with advancements in serologic diagnosis of allergy, changes in immunotherapy and use of immunobiologicals.

This is our reality and we need to think strategically about how to position the specialty for future success, especially when you consider the areas where we can make an impact...